Disease | neurofibromatosis |
Comorbidity | C0027809|schwannoma |
Sentences | 12 |
PubMedID- 23453897 | We present a case of macrodactyly of the small finger associated with a digital nerve plexiform schwannoma in a patient with neurofibromatosis type 2. |
PubMedID- 20736812 | We sought to determine the activity of erlotinib for progressive vestibular schwannoma (vs) associated with neurofibromatosis 2 (nf2). |
PubMedID- 23351479 | Although abnormal gag reflexes have been reported in cases of glossopharyngeal schwannoma and neurofibroma in patients with neurofibromatosis-1, a gag reflex has not been reported previously as a complication of im in the head and neck. |
PubMedID- 26287269 | Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2. |
PubMedID- 23413263 | Loss of the merlin tumour suppressor causes abnormal de-differentiation and proliferation of schwann cells and formation of schwannoma tumours in patients with neurofibromatosis type 2. |
PubMedID- 24338149 | Pediatric intramedullary schwannoma without neurofibromatosis is extremely rare with only five cases reported so far. |
PubMedID- 21817944 | Objectives: to discuss our management strategy of vestibular schwannoma in patients with neurofibromatosis type 2 (nf2). |
PubMedID- 24335931 | Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. |
PubMedID- 22805104 | Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. |
PubMedID- 23649401 | schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging. |
PubMedID- 26108240 | Bevacizumab treatment for vestibular schwannoma in a patient with neurofibromatosis type 2: hearing improvement and tumor shrinkage. |
PubMedID- 25362541 | Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review. |
Page: 1